Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-12-24
1995-07-11
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 2, 514 11, 514171, 514289, 514327, A61K 31495, A61K 3150, A61K 3700, A61K 3156
Patent
active
054321760
ABSTRACT:
Progression of chronic renal failure can be retarded or arrested by administering to humans suffering from such disorder an agent which suppresses the production of glucocorticoids in the human together with a glucocorticoid. An example of an agent which suppresses the production of glucocorticoids includes ketoconazole. Exemplary of the glucocorticoid is prednisone.
REFERENCES:
patent: 3714159 (1973-01-01), Janssen et al.
patent: 4107306 (1978-08-01), Voorhees
patent: 4320146 (1982-03-01), Walser
Remington's Pharmaceutical Sciences, 16th edition, 1980, pp. 1858-1859.
M. Moguilewsky, et al., "RU 38486: Potent Antiglucocorticoid Activity Correlated with Strong Binding to the Cytosolic Glucocorticoid Receptor Followed by anImpaired Activation", S. Steroid Biochem, vol. 20, No. 1, pp. 271-276 (1984).
Roland M. Schaefer, et al., "Evidence for Reduced Catabolism by the Antiglucocorticoid RU 38486 in Acutely Uremic Rats", Am. J. Nephrol, 7, pp. 127-131 (1987).
Xavier Bertagna, et al., "The New Steroid Analog RU 486 Inhibits Glucocorticoid Action in Man", Journal of Clinical Endocrinology and Metabolism, vol. 59, No. 1, pp. 25-28 (1984).
N. Gretz, et al., "Low-proteindiet supplemented by keto acids in chronic renal failure: A prospective controlled study", Kidney International, vol. 24, Suppl. 16 (1983), pp. S-263-S-267.
M. Walser, "Ketoacids in the treatment of uremia*", Clinical Nephrology, vol. 3 No. 5 (1975).
G. Barsotti, et al., "Effects on Renal Function of a Low-Nitrogen Diet Supplemented with Essential Amino Acids and Ketoanalogues and of Hemodialysis and Free Protein Supply in Patients with Chronic Renal Failure", Nephron 27:113-117 (1981).
W. E. Mitch, et al., "The Effect of Keto Acid-Amino Acid Supplement to Restricted Diet on the Progression of Chronic Renal Failure", The New England Journal of Medicine, 311:623-629 (Sep. 6), 1984.
J. Burns, et al., "Comparison of the effects of keto acid analogues and essential amino acids on nitrogen homeostasis in uremic patients on moderately protein-restricted diets", The American Journal of Clinical Nutrition 31: Oct. 1978, pp. 1767-1775.
M. Walser, et al., "Progression of chronic renal failure in patients given ketoacids following amino acids", Kidney International, vol. 32 (1987), pp. 123-128.
Nieman, et al., "Clinical Applications of the Glucocorticoid and Progestin Atnagonist RU 486," appearing in Receptor Mediated Antisteroid Action/Editor M. K. Agarwal (1987).
Gagne, et al., "RU38486: A Potent Antiglucocorticoid in Vitro and In Vivo," J. Steriod Biochem, vol. 23, No. 3, pp. 247-251 (1985).
Mitch, et al., "Long-Term Effects of a New Ketoacid-Amino Acid Supplement in Patients with Chronic Renal Failure," Kidney International, 22:48-53 (1982).
Pende, et al., "Evaluation of the Effects Induced by Four Opiate Drugs, with Different Affinities to Opioid Receptor Subtypes, on ANterior Pituitary LH, TSH, PRL and GH Secretion and on Cortisol Secretion in Normal Men," Biomedicine & Pharmacotherapy, 1986, 40, 178-182.
Aggernaes, et al., "The Effect of Sodium Valproate on Serum Cortisol Levels in Healthy Subjects and Depressed Patients," Acta Psychiatr. Scand. 1988:77:170-174.
Lechin, et al., "Role of Stress in the Exacerbation of Chronic Illness: Effects of Clonidine Administration on Blood Pressure and Plasma Norepinephrine, Cortisol, Growth Hormone and Prolactin Concentrations," Psychoneuroendocrinology, vol. 12, No. 2 pp. 117-129 (1987).
Stubbs, et al., "Hormonal and Metabolic Responses to an Enkephalin Analogue in Normal Man," The Lancet, Dec. 9, 1978, pp. 1225-1227.
J. J. Legros, et al., "Confirmation of the Inhibitory Influence of Exogenous Oxytocin on Cortisol and ACTH in Man: Evidence of Reproducibility", Acta Endocrinologica, 114: pp. 345-349 (1987).
Farwell, et a., "Total Suppression of Cortisol Excretion by Ketoconazole in the Therapy of the Ectopic Adrenocorticotropic Hormone Syndrome", The American Journal of Medicine, vol. 84 (Jun. 1988), pp. 1063-1066.
Stowinski-Srzednicka, et al., "Effect of Clonidine on Beta-Endorphin, ACTH and Cortisol Secretion in Essential Hypertension and Obesity," Eur. J. Clin. Pharmacol (1988) 35:115-121.
Jonathan R. Diamond, M.D., "Physiology and Cell Biology Update--The Role of Reactive Oxygen Species in Animal Models of Glomerular Disease," Am Journal of Kidney Diseases XIX. No. 3, pp. 292-300 (1992).
Satoru Matsusue et al., "Healing of Intestinal Anastomoses in Adrenalectomized Rats Given Corticosterone," Am. J. Physiol. 263, pp. R164-R168 (1992).
J. M. Villette et al., "Circadian Variations in Plasma Levels of Hypophyseal, Adrenocortical and Testicular Hormones in Men Infected with Human Immunodeficiency Virus," Journal of Clinical Endocrinology & Metabolism 70, pp. 572-577 (1990).
Mackenzie Walser et al., "Progression of Chronic Renal Failure on Substituting a Ketoacid Supplement for an Amino Acid Supplement," J. Am. Soc. Nephrol., 2, pp. 1178-1185 (1992).
B. Ulrich et al., "Pharmacokinetics/Pharmacodynamics of Ketoconazole-Prednisolone Interaction," J. Pharmacol. Exp. Ther. 260, No. 2, pp. 487-490 (1992).
Helen Wiseman et al., "The Antioxidant Action of Ketoconazole and Related Azoles: Comparison with Tamoxifen and Cholesterol," Chem.-Biol. Interactions 79, pp. 229-243 (1991).
T. Taylor, et al., "B-Endorphin Suppresses Adrenocorticotropin and Cortisol Levels in Normal Human Subjects", Journal of Clinical Endocripology and Metabolism, vol. 57, No. 3, pp. 592-596 (1983).
B. Ambrosi, et al., "Loperamide, and Opiate Analogue, Inhibits Plasma Acth Levels in Patients with Addison's Disease", Clinical endocrinlogy, 24, pp. 483-489 (1986).
G. Teutsch, et al., "17a-Alkynyl-11b, 17-Dihydroxyandrostane Derivatives: A New Class of Potent Glucocortincoids.", Steriods, vol. 38, No. 6, pp. 651-665 (1981).
Beverley E. Pearson, et al. "Response To Steriod Suppression In Major Depression Resistant To Antidepressant Therapy", Journal of Clinical Psychopharmacology, vol. 11/No. 2, Apr. 1991.
Henley III Raymond
The John Hopkins University
LandOfFree
Method of retarding the progression of chronic renal failure does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of retarding the progression of chronic renal failure, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of retarding the progression of chronic renal failure will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-503600